Please enable Javascript

Labmeeting uses lots of Javascript - basically you can't use the site without it. So please enable Javascript in your browser. If your browser does not support Javascript, we recommend Firefox.

Papers authored by Guilloteau D

Collect these papers and discover other ones on Labmeeting. Learn more.

Behavior and serotonergic disorders in rats exposed prenatally to valproate: a model for autism.

+ cite this

+ View Abstract

Dufour-Rainfray D, Vourc'h P, Le Guisquet AM, Garreau L, Ternant D, Bodard S, Jaumain E, Gulhan Z, Belzung C, Andres CR, Chalon S, and Guilloteau D

Neuroscience letters 470(1):55-9, 2010 Feb 5 - Who cited this? | PubMed ID: 20036713 | Fulltext

Synthesis and in vitro evaluation of fluorinated diphenyloxide derivatives and sulfur analogs as serotonin transporter ligands.

+ cite this

+ View Abstract

Mavel S, Meheux N, Guilloteau D, and Emond P

Bioorganic & medicinal chemistry 18(1):236-41, 2010 Jan 1 - Who cited this? | PubMed ID: 19926484 | Fulltext

In vitro autoradiography and in vivo evaluation in cynomolgus monkey of [18F]FE-PE2I, a new dopamine transporter PET radioligand.

+ cite this

+ View Abstract

Varrone A, Steiger C, Schou M, Takano A, Finnema SJ, Guilloteau D, Gulyás B, and Halldin C

Synapse (New York, N.Y.) 63(10):871-80, 2009 Oct - Who cited this? | PubMed ID: 19562698 | Fulltext

Synthesis, radiolabeling and preliminary in vivo evaluation of [18F]FE-PE2I, a new probe for the dopamine transporter.

+ cite this

+ View Abstract

Schou M, Steiger C, Varrone A, Guilloteau D, and Halldin C

Bioorganic & medicinal chemistry letters 19(16):4843-5, 2009 Aug 15 - Who cited this? | PubMed ID: 19577467 | Fulltext

Evaluation of CLINDE as potent translocator protein (18 kDa) SPECT radiotracer reflecting the degree of neuroinflammation in a rat model of microglial activation.

+ cite this

Arlicot N, Katsifis A, Garreau L, Mattner F, Vergote J, Duval S, Kousignian I, Bodard S, Guilloteau D, and Chalon S

European journal of nuclear medicine and molecular imaging 35(12):2341, 2008 Dec - Who cited this? | PubMed ID: 19082591 | Fulltext

Guideline to regulations for radiopharmaceuticals in early phase clinical trials in the EU.

+ cite this

+ View Abstract

Verbruggen A, Coenen HH, Deverre JR, Guilloteau D, Langstrom B, Salvadori PA, and Halldin C

European journal of nuclear medicine and molecular imaging 35(11):2144-51, 2008 Nov - Who cited this? | PubMed ID: 18690437 | Fulltext

Docking study, synthesis, and in vitro evaluation of fluoro-MADAM derivatives as SERT ligands for PET imaging.

+ cite this

+ View Abstract

Mavel S, Vercouillie J, Garreau L, Raguza T, Ravna AW, Chalon S, Guilloteau D, and Emond P

Bioorganic & medicinal chemistry, 2008 Aug 6 - Who cited this? | PubMed ID: 18793858 | Fulltext

Evaluation of CLINDE as potent translocator protein (18 kDa) SPECT radiotracer reflecting the degree of neuroinflammation in a rat model of microglial activation.

+ cite this

+ View Abstract

Arlicot N, Katsifis A, Garreau L, Mattner F, Vergote J, Duval S, Bodard S, Guilloteau D, and Chalon S

European journal of nuclear medicine and molecular imaging, 2008 Jun 7 - Who cited this? | PubMed ID: 18536913 | Fulltext

Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease.

+ cite this

+ View Abstract

Bouchez G, Sensebé L, Vourc'h P, Garreau L, Bodard S, Rico A, Guilloteau D, Charbord P, Besnard JC, and Chalon S

Neurochemistry international 52(7):1332-42, 2008 Jun - Who cited this? | PubMed ID: 18372079 | Fulltext

DPA-714, a new translocator protein-specific ligand: synthesis, radiofluorination, and pharmacologic characterization.

+ cite this

+ View Abstract

James ML, Fulton RR, Vercoullie J, Henderson DJ, Garreau L, Chalon S, Dolle F, Selleri S, Guilloteau D, and Kassiou M

Journal of nuclear medicine : official publication, Society of Nuclear Medicine 49(5):814-22, 2008 May - Who cited this? | PubMed ID: 18413395 | Fulltext

In vivo SPECT imaging of vesicular acetylcholine transporter using [(123)I]-IBVM in early Alzheimer's disease.

+ cite this

+ View Abstract

Mazère J, Prunier C, Barret O, Guyot M, Hommet C, Guilloteau D, Dartigues JF, Auriacombe S, Fabrigoule C, and Allard M

NeuroImage 40(1):280-8, 2008 Mar 1 - Who cited this? | PubMed ID: 18191587 | Fulltext

PE2I: A Radiopharmaceutical for In vivo Exploration of the Dopamine Transporter.

+ cite this

+ View Abstract

Emond P, Guilloteau D, and Chalon S

CNS neuroscience & therapeutics 14(1):47-64, 2008 Mar - Who cited this? | PubMed ID: 18482099 | Fulltext

IMPY, a potential beta-amyloid imaging probe for detection of prion deposits in scrapie-infected mice.

+ cite this

+ View Abstract

Song PJ, Bernard S, Sarradin P, Vergote J, Barc C, Chalon S, Kung MP, Kung HF, and Guilloteau D

Nuclear medicine and biology 35(2):197-201, 2008 Feb - Who cited this? | PubMed ID: 18312829 | Fulltext

Improved synthesis and metabolic stability analysis of the dopamine transporter ligand [(18)F]FECT.

+ cite this

+ View Abstract

Chitneni SK, Garreau L, Cleynhens B, Evens N, Bex M, Vermaelen P, Chalon S, Busson R, Guilloteau D, Van Laere K, Verbruggen A, and Bormans G

Nuclear medicine and biology 35(1):75-82, 2008 Jan - Who cited this? | PubMed ID: 18158946 | Fulltext

Gut emptying affects dietary fat contribution to postprandial lipemia following sequential meals in healthy subjects.

+ cite this

+ View Abstract

Maillot F, Baulieu F, Guilloteau D, Boirie Y, Garrigue MA, Hoinard C, and Couet C

Nutrition (Burbank, Los Angeles County, Calif.) 24(7-8):682-8, 2008 - Who cited this? | PubMed ID: 18486449 | Fulltext

Ex vivo and in vivo evaluation of (2R,3R)-5-[(18)F]-fluoroethoxy- and fluoropropoxy-benzovesamicol, as PET radioligands for the vesicular acetylcholine transporter.

+ cite this

+ View Abstract

Giboureau N, Emond P, Fulton RR, Henderson DJ, Chalon S, Garreau L, Roselt P, Eberl S, Mavel S, Bodard S, Fulham MJ, Guilloteau D, and Kassiou M

Synapse (New York, N.Y.) 61(12):962, 2007 Dec - Who cited this? | PubMed ID: 17787004 | Fulltext

(E)-[125I]-5-AOIBV: a SPECT radioligand for the vesicular acetylcholine transporter.

+ cite this

+ View Abstract

Emond P, Mavel S, Zea-Ponce Y, Kassiou M, Garreau L, Bodard S, Drossard ML, Chalon S, and Guilloteau D

Nuclear medicine and biology 34(8):967, 2007 Nov - Who cited this? | PubMed ID: 17998100 | Fulltext

Evaluation of a solid bolus suitable for esophageal scintigraphy.

+ cite this

+ View Abstract

Baulieu F, Boiron M, Bertrand P, Guilloteau D, Baulieu JL, and Metman EH

Dysphagia 22(4):281-9, 2007 Oct - Who cited this? | PubMed ID: 17554473 | Fulltext

New fluoro-diphenylchalcogen derivatives to explore the serotonin transporter by PET.

+ cite this

+ View Abstract

Vercouillie J, Deuther-Conrad W, Scheunemann M, Emond P, Fischer S, Funke U, Steinbach J, Guilloteau D, and Brust P

Bioorganic & medicinal chemistry letters 17(17):4991-5, 2007 Sep 1 - Who cited this? | PubMed ID: 17658253 | Fulltext

Decreased vesicular acetylcholine transporter and alpha(4)beta(2) nicotinic receptor density in the rat brain following 192 IgG-saporin immunolesioning.

+ cite this

+ View Abstract

Quinlivan M, Chalon S, Vergote J, Henderson J, Katsifis A, Kassiou M, and Guilloteau D

Neuroscience letters 415(2):97-101, 2007 Mar 26 - Who cited this? | PubMed ID: 17339079 | Fulltext

Ageing and reproduction: is polycystic ovary syndrome an exception?.

+ cite this

+ View Abstract

Vulpoi C, Lecomte C, Guilloteau D, and Lecomte P

Annales d'endocrinologie 68(1):45-50, 2007 Feb - Who cited this? | PubMed ID: 17316546 | Fulltext

[11C]LBT-999: a suitable radioligand for investigation of extra-striatal dopamine transporter with PET.

+ cite this

+ View Abstract

Saba W, Valette H, Schöllhorn-Peyronneau MA, Coulon C, Ottaviani M, Chalon S, Dolle F, Emond P, Halldin C, Helfenbein J, Madelmont JC, Deloye JB, Guilloteau D, and Bottlaender M

Synapse (New York, N.Y.) 61(1):17-23, 2007 Jan - Who cited this? | PubMed ID: 17068778 | Fulltext

Acetylenic pyridines for use in PET imaging of nicotinic receptors.

+ cite this

Kozikowski AP, Chellappan SK, Henderson D, Fulton R, Giboureau N, Xiao Y, Wei ZL, Guilloteau D, Emond P, Dolle F, Kellar KJ, and Kassiou M

ChemMedChem 2(1):54-7, 2007 Jan - Who cited this? | PubMed ID: 17096450 | Fulltext

Synthesis and in vitro evaluation of N-substituted aza-trozamicol analogs as vesicular acetylcholine transporter ligands.

+ cite this

+ View Abstract

Assaad T, Mavel S, Parsons SM, Kruse S, Galineau L, Allouchi H, Kassiou M, Chalon S, Guilloteau D, and Emond P

Bioorganic & medicinal chemistry letters 16(10):2654-7, 2006 May 15 - Who cited this? | PubMed ID: 16516472 | Fulltext

Pharmacological characterization of (E)-N-(4-fluorobut-2-enyl)-2beta-carbomethoxy-3beta-(4'-tolyl)nortropane (LBT-999) as a highly promising fluorinated ligand for the dopamine transporter.

+ cite this

+ View Abstract

Chalon S, Hall H, Saba W, Garreau L, Dollé F, Halldin C, Emond P, Bottlaender M, Deloye JB, Helfenbein J, Madelmont JC, Bodard S, Mincheva Z, Besnard JC, and Guilloteau D

The Journal of pharmacology and experimental therapeutics 317(1):147-52, 2006 Apr - Who cited this? | PubMed ID: 16339913 | Fulltext

Synthesis and biological evaluation of a series of flavone derivatives as potential radioligands for imaging the multidrug resistance-associated protein 1 (ABCC1/MRP1).

+ cite this

+ View Abstract

Mavel S, Dikic B, Palakas S, Emond P, Greguric I, de Gracia AG, Mattner F, Garrigos M, Guilloteau D, and Katsifis A

Bioorganic & medicinal chemistry 14(5):1599-607, 2006 Mar 1 - Who cited this? | PubMed ID: 16263302 | Fulltext

Synthesis and in vitro evaluation of novel derivatives of diphenylsulfide as serotonin transporter ligands.

+ cite this

+ View Abstract

Vercouillie J, Mavel S, Galineau L, Ragusa T, Innis R, Kassiou M, Chalon S, Dollé F, Besnard JC, Guilloteau D, and Emond P

Bioorganic & medicinal chemistry letters 16(5):1297-300, 2006 Mar 1 - Who cited this? | PubMed ID: 16337793 | Fulltext

Synthesis, radiosynthesis and in vivo preliminary evaluation of [11C]LBT-999, a selective radioligand for the visualisation of the dopamine transporter with PET.

+ cite this

+ View Abstract

Dollé F, Emond P, Mavel S, Demphel S, Hinnen F, Mincheva Z, Saba W, Valette H, Chalon S, Halldin C, Helfenbein J, Legaillard J, Madelmont JC, Deloye JB, Bottlaender M, and Guilloteau D

Bioorganic & medicinal chemistry 14(4):1115-25, 2006 Feb 15 - Who cited this? | PubMed ID: 16219467 | Fulltext

Comparative analysis of different scintigraphic approaches to assess pulmonary ventilation.

+ cite this

+ View Abstract

Magnant J, Vecellio L, de Monte M, Grimbert D, Valat C, Boissinot E, Guilloteau D, Lemarié E, and Diot P

Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine 19(2):148-59, 2006 - Who cited this? | PubMed ID: 16796539 | Fulltext

[(11)C]MADAM, a new serotonin transporter radioligand characterized in the monkey brain by PET.

+ cite this

+ View Abstract

Halldin C, Lundberg J, Sóvágó J, Gulyás B, Guilloteau D, Vercouillie J, Emond P, Chalon S, Tarkiainen J, Hiltunen J, and Farde L

Synapse (New York, N.Y.) 58(3):173-83, 2005 Dec 1 - Who cited this? | PubMed ID: 16138320 | Fulltext

Prenatal 3,4-methylenedioxymethamphetamine (ecstasy) exposure induces long-term alterations in the dopaminergic and serotonergic functions in the rat.

+ cite this

+ View Abstract

Galineau L, Belzung C, Kodas E, Bodard S, Guilloteau D, and Chalon S

Brain research. Developmental brain research 154(2):165-76, 2005 Feb 8 - Who cited this? | PubMed ID: 15707670 | Fulltext

Cholinergic nicotinic receptor involvement in movement disorders associated with Lewy body diseases. An autoradiography study using [(125)I]alpha-conotoxinMII in the striatum and thalamus.

+ cite this

+ View Abstract

Bohr IJ, Ray MA, McIntosh JM, Chalon S, Guilloteau D, McKeith IG, Perry RH, Clementi F, Perry EK, Court JA, and Piggott MA

Experimental neurology 191(2):292-300, 2005 Feb - Who cited this? | PubMed ID: 15649484 | Fulltext

Synthesis and in vitro evaluation of new benzovesamicol analogues as potential imaging probes for the vesicular acetylcholine transporter.

+ cite this

+ View Abstract

Zea-Ponce Y, Mavel S, Assaad T, Kruse SE, Parsons SM, Emond P, Chalon S, Giboureau N, Kassiou M, and Guilloteau D

Bioorganic & medicinal chemistry 13(3):745-53, 2005 Feb 1 - Who cited this? | PubMed ID: 15653342 | Fulltext

PET and SPECT exploration of central monoaminergic transporters for the development of new drugs and treatments in brain disorders.

+ cite this

+ View Abstract

Guilloteau D and Chalon S

Current pharmaceutical design 11(25):3237-45, 2005 - Who cited this? | PubMed ID: 16250852 | Fulltext

Involvement of alpha6/alpha3 neuronal nicotinic acetylcholine receptors in neuropsychiatric features of Dementia with Lewy bodies: [(125)I]-alpha-conotoxin MII binding in the thalamus and striatum.

+ cite this

+ View Abstract

Ray M, Bohr I, McIntosh JM, Ballard C, McKeith I, Chalon S, Guilloteau D, Perry R, Perry E, Court JA, and Piggott M

Neuroscience letters 372(3):220-5, 2004 Dec 6 - Who cited this? | PubMed ID: 15542244 | Fulltext

Ontogeny of the dopamine and serotonin transporters in the rat brain: an autoradiographic study.

+ cite this

+ View Abstract

Galineau L, Kodas E, Guilloteau D, Vilar MP, and Chalon S

Neuroscience letters 363(3):266-71, 2004 Jun 17 - Who cited this? | PubMed ID: 15182957 | Fulltext

ADAM is an effective tool for in vivo study of serotonergic function: validation in rat models.

+ cite this

+ View Abstract

Chalon S, Bronquard C, Vercouillie J, Kodas E, Garreau L, Bodard S, Emond P, Besnard JC, and Guilloteau D

Synapse (New York, N.Y.) 52(2):136-42, 2004 May - Who cited this? | PubMed ID: 15034919 | Fulltext

Serotoninergic neurotransmission is affected by n-3 polyunsaturated fatty acids in the rat.

+ cite this

+ View Abstract

Kodas E, Galineau L, Bodard S, Vancassel S, Guilloteau D, Besnard JC, and Chalon S

Journal of neurochemistry 89(3):695-702, 2004 May - Who cited this? | PubMed ID: 15086526 | Fulltext

Time-course of nigrostriatal degeneration in a progressive MPTP-lesioned macaque model of Parkinson's disease.

+ cite this

+ View Abstract

Meissner W, Prunier C, Guilloteau D, Chalon S, Gross CE, and Bezard E

Molecular neurobiology 28(3):209-18, 2003 Dec - Who cited this? | PubMed ID: 14709785 | Fulltext

Synthesis and evaluation of iodine-123 labelled tricyclic tropanes as radioligands for the serotonin transporter.

+ cite this

+ View Abstract

Quinlivan M, Mattner F, Papazian V, Zhou J, Katsifis A, Emond P, Chalon S, Kozikowski A, Guilloteau D, and Kassiou M

Nuclear medicine and biology 30(7):741-6, 2003 Oct - Who cited this? | PubMed ID: 14499332 | Fulltext

[(11)C]PE2I: a highly selective radioligand for PET examination of the dopamine transporter in monkey and human brain.

+ cite this

+ View Abstract

Halldin C, Erixon-Lindroth N, Pauli S, Chou YH, Okubo Y, Karlsson P, Lundkvist C, Olsson H, Guilloteau D, Emond P, and Farde L

European journal of nuclear medicine and molecular imaging 30(9):1220-30, 2003 Sep - Who cited this? | PubMed ID: 12811422 | Fulltext

Hypoxic preconditioning reduces apoptosis in a rat model of immature brain hypoxia-ischaemia.

+ cite this

+ View Abstract

Cantagrel S, Krier C, Ducrocq S, Bodard S, Payen V, Laugier J, Guilloteau D, and Chalon S

Neuroscience letters 347(2):106-10, 2003 Aug 21 - Who cited this? | PubMed ID: 12873739 | Fulltext

Presymptomatic diagnosis of experimental Parkinsonism with 123I-PE2I SPECT.

+ cite this

+ View Abstract

Prunier C, Bézard E, Montharu J, Mantzarides M, Besnard JC, Baulieu JL, Gross C, Guilloteau D, and Chalon S

NeuroImage 19(3):810-6, 2003 Jul - Who cited this? | PubMed ID: 12880809 | Fulltext

Quantification of dopamine transporter by 123I-PE2I SPECT and the noninvasive Logan graphical method in Parkinson's disease.

+ cite this

+ View Abstract

Prunier C, Payoux P, Guilloteau D, Chalon S, Giraudeau B, Majorel C, Tafani M, Bezard E, Esquerré JP, and Baulieu JL

Journal of nuclear medicine : official publication, Society of Nuclear Medicine 44(5):663-70, 2003 May - Who cited this? | PubMed ID: 12732666 | Fulltext

Pharmacological characterization of N,N-dimethyl-2-(2-amino-4-methylphenyl thio)benzylamine as a ligand of the serotonin transporter with high affinity and selectivity.

+ cite this

+ View Abstract

Chalon S, Tarkiainen J, Garreau L, Hall H, Emond P, Vercouillie J, Farde L, Dasse P, Varnas K, Besnard JC, Halldin C, and Guilloteau D

The Journal of pharmacology and experimental therapeutics 304(1):81-7, 2003 Jan - Who cited this? | PubMed ID: 12490578 | Fulltext

Motor behaviour deficits and their histopathological and functional correlates in the nigrostriatal system of dopamine transporter knockout mice.

+ cite this

+ View Abstract

Fernagut PO, Chalon S, Diguet E, Guilloteau D, Tison F, and Jaber M

Neuroscience 116(4):1123-30, 2003 - Who cited this? | PubMed ID: 12617953 | Fulltext

Synthesis and biological evaluation of halogenated naphthyridone carboxamides as potential ligands for in vivo imaging studies of substance P receptors.

+ cite this

+ View Abstract

Bagot-Guéret C, Le Bas MD, Tymciu S, Darabantu M, Emond P, Guilloteau D, Lasne MC, Wijkhuisen A, Barré L, and Perrio C

Bioconjugate chemistry 14(3):629-41, 2003 - Who cited this? | PubMed ID: 12757389 | Fulltext

Synthesis, radiolabeling and preliminary biological evaluation of radiolabeled 5-methyl-6-nitroquipazine, a potential radioligand for the serotonin transporter.

+ cite this

+ View Abstract

Sandell J, Yu M, Emond P, Garreau L, Chalon S, Någren K, Guilloteau D, and Halldin C

Bioorganic & medicinal chemistry letters 12(24):3611-3, 2002 Dec 16 - Who cited this? | PubMed ID: 12443787 | Fulltext

Reversibility of n-3 fatty acid deficiency-induced changes in dopaminergic neurotransmission in rats: critical role of developmental stage.

+ cite this

+ View Abstract

Kodas E, Vancassel S, Lejeune B, Guilloteau D, and Chalon S

Journal of lipid research 43(8):1209-19, 2002 Aug - Who cited this? | PubMed ID: 12177165 | Fulltext

PET examination of [(11)C]5-methyl-6-nitroquipazine, a radioligand for visualization of the serotonin transporter.

+ cite this

+ View Abstract

Sandell J, Halldin C, Sovago J, Chou YH, Gulyás B, Yu M, Emond P, Någren K, Guilloteau D, and Farde L

Nuclear medicine and biology 29(6):651-6, 2002 Aug - Who cited this? | PubMed ID: 12234589 | Fulltext

Search Google Scholar for Guilloteau D

Join Labmeeting

Organize and search your PDF collection
Collect papers
Search millions of papers
Keep up to date with paper alerts
Read your papers from anywhere
Recommend papers to colleagues
Manage your lab

Labmeeting is a web service for researchers. Sign up with your academic email address.

Individuals or corporations not affiliated with an academic institution can request a trial subscription.